457. Deputy Ruth Coppinger asked the Minister for Health further to Parliamentary Questions Nos. 1632 and 1633 of 4 November 2025, whether healthcare providers must indicate eligibility/ineligibility for the free HRT scheme on the prescriptions transmitted to pharmacists; and if she will make a statement on the matter. [62489/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
965. Deputy Conor Sheehan asked the Minister for Health her plans to roll out a long-acting injection to prevent HIV, as was done by NHS England recently; and if she will make a statement on the matter. [61225/25]
1021. Deputy Michael Healy-Rae asked the Minister for Health the status of an application for medication by a person (details supplied); and if she will make a statement on the matter. [61600/25]
382. Deputy Ken O'Flynn asked the Minister for Health when her Department intends to complete the review of national policy governing the use of medications issued under special licence, as recommended by the Cork city coroner in December 2024; the expected date for finalisation of new protocols on hospital administration and clinician supervision; and if she will make a statement on the matter. [60516/25]
383. Deputy Ken O'Flynn asked the Minister for Health if her Department has directed the HSE to issue interim guidance or a temporary clinical protocol governing the administration, supervision and recording of special-licence medications in hospitals pending the completion of a full policy review; if she will publish that guidance; and if she will make a statement on the matter. [60517/25]
384. Deputy Ken O'Flynn asked the Minister for Health the number of patients currently in receipt of medications under special licence in Ireland; the number of such patients admitted to hospital in each of the past five years; and the measures being taken to ensure their medication administration is governed by clear and consistent protocols nationwide. [60518/25]
449. Deputy Malcolm Byrne asked the Minister for Health when a person (details supplied) can receive the approved drug repatha (evolocumab) as prescribed; and the current availability of the drug. [60770/25]
459. Deputy Pádraig Rice asked the Minister for Health the number of people on a waiting list for pre-exposure prophylaxis (PrEP) by clinic; and the wait time to be offered a new appointment in each clinic, in tabular form. [60783/25]
482. Deputy Martin Daly asked the Minister for Health the number that have availed of the free HRT scheme since its introduction; and if she will make a statement on the matter. [60878/25]
176. Deputy Colm Burke asked the Minister for Health to outline the number of new medicines which were submitted to the NCPE in each year between 2015 and 2025; and the number of these new medicines that were non-oncology orphan medicinal products, in tabular form; and if she will make a statement on the matter. [60301/25]
177. Deputy Colm Burke asked the Minister for Health to outline the number of non-oncology orphan medicinal products which were referred to the HSE Drugs Group by the NCPE in each year between 2015 and 2025; and to provide a breakdown of the number of successful, negative and pending reimbursement decisions for such products, in tabular form; and if she will make a statement on the matter. [60302/25]
178. Deputy Colm Burke asked the Minister for Health the average length of time taken for non-oncology orphan medicines to receive a final reimbursement decision from the HSE Drugs Group after the submission of a pricing application by a manufacturer, in tabular form; and if she will make a statement on the matter. [60303/25]
179. Deputy Colm Burke asked the Minister for Health the number of non-oncology orphan medicines which were approved by the HSE drugs group in each year from 2015 to 2025 and which did not satisfy the QALY threshold for cost-effectiveness, in tabular form; and if she will make a statement on the matter. [60304/25]
180. Deputy Colm Burke asked the Minister for Health the number of new medicines which were submitted to the NCPE in each year between 2015 and 2025; to provide a breakdown of the number of these new medicines that were non-oncology orphan medicinal products, in tabular form; and if she will make a statement on the matter. [60305/25]
181. Deputy Colm Burke asked the Minister for Health the number of non-oncology orphan medicinal products which were referred to the HSE drugs group by the NCPE in each year between 2015 and 2025; to provide a breakdown of the number of successful, negative and pending reimbursement decisions for such products, in tabular form; and if she will make a statement on the matter. [60306/25]
182. Deputy Colm Burke asked the Minister for Health the average length of time taken for non-oncology orphan medicines to receive a final reimbursement decision from the HSE drugs group after the submission of a pricing application by a manufacturer, in tabular form; and if she will make a statement on the matter. [60307/25]
183. Deputy Cathy Bennett asked the Minister for Health her proposals to ensure that patients are not forced to absorb the cost of blister-pack packaged medication, which assists patients to monitor their dosage under complex medication regimes safely and independently; and if she will make a statement on the matter. [60312/25]
1635. Deputy Ryan O'Meara asked the Minister for Health if ozempic, is available under the drugs payment scheme (DPS) or general medical services card for patients who have had it prescribed; if not, whether there are alternatives available under the DPS/GMS that a patient may instead discuss with their GP; and if she will make a statement on the matter. [57820/25]
1636. Deputy Ryan O'Meara asked the Minister for Health if ozempic, is available to a GMS patient (details supplied) who has been prescribed same by their endocrinologist and diabetes specialist; and if she will make a statement on the matter. [57821/25]
1650. Deputy Marie Sherlock asked the Minister for Health the steps she will take to engage with the market authorisation holders of medications (details supplied) to submit pricing and reimbursement applications for these drug treatments to commence in patients over 18 years of age who are diagnosed with spinal muscular atrophy; and if she will make a statement on the matter. [57883/25]
1712. Deputy Emer Currie asked the Minister for Health to consider making melatonin available through the drugs payment scheme for neurodiverse children to assist with sleeping; and if she will make a statement on the matter. [58108/25]
1758. Deputy Ruth Coppinger asked the Minister for Health the timeline for the approval of linzagolix by the National Centre for Pharmacoeconomics for the public prescription of this particular drug; and if she will make a statement on the matter. [58304/25]
1817. Deputy Marie Sherlock asked the Minister for Health if consideration has been given to including the shingles vaccine (Herpes Zoster Vaccine) in the national immunisation programme, specifically for those with immunocompromising conditions, as recommended by NIAC in February 2024; and if she will make a statement on the matter. [58694/25]
1819. Deputy Pádraig O'Sullivan asked the Minister for Health the steps being taken to ensure a life changing prostate cancer medication (details supplied) will be made available to medically suitable patients; and if she will make a statement on the matter. [58715/25]
1994. Deputy Pádraig Mac Lochlainn asked the Minister for Health when a medication (details supplied) will be available again here, for prescription for patients of the menopause hub; and if she will make a statement on the matter. [59569/25]